> Japan's Astellas Pharma is denying media reports that it is taking out an $8.6 billion loan for acquisitions. Report
> Genizon BioSciences has closed a first tranche of $12.4 million in convertible debentures. Release
> RenaMed Biologics is moving its corporate headquarters from Lincoln, RI to Westborough, MA this summer as it relocates close to Genzyme, its manufacturing partner. Report
> United Therapeutics plans to invest about $55 million in a new facility at Research Triangle Park, hiring some 160 workers. Report
> The FDA has approved Aurobindo Pharma' Zidovudine capsules for AIDS. Release
> Shares of Nanogen jumped on the FDA's approval of its congestive heart failure plasma test. Report
> GlaxoSmithKline has agreed to pay $14 million to state Medicaid programs to settle claims it blocked a generic competitor to Paxil. Report
> The FDA has approved the use of Relenza for the prevention flu in adults and children 5 years of age and older. Release
> A study of GSK's Advair found an encouraging trend line but failed to achieve statistical significance in reducing mortality rates. Report
> Caprion Pharmaceuticals's Applied BioMedicine group announced a research collaboration with Vertex Pharmaceuticals for discovering new biomarkers. Release
And Finally... Chinese researchers have shown that antibodies from horses vaccinated for H5N1 proved effective in protecting mice from the virus. Article